Clinical Oncology

Staff

19001
Chief
Yusuke Onozawa, M.D.

Features of Clinical Oncology

In general, a cancer originates in a certain organ, and spreads to other organs as it progresses. Even when it metastasizes, it is considered that it takes on the characteristics of the primary tumor and the treatment method will be tailored in accordance with it. However, there is a case sometimes that only the metastasized tumor is detected when it is diagnosed, and even with various examinations, the primary tumor may remain unknown. In a case as such, it is called “cancer of unknown primary” and the Division of Clinical Oncology will be responsible for the treatment of that type of cancer.

Features and Therapeutic Strategies of the Division at the SCC

Various tests and examinations will lead to identification of primary tumor.

Cancer of unknown primary is submitted to pathological tests and diagnostic imaging in search of its origin or clues to help presume it. Having an experienced medical staff, including skilled pathologists, often leads to the successful identification of the primary lesion.

Optimal treatment is provided in collaboration with many clinical departments even when the primary lesion remains unknown.

Even with extensive tests and examinations, the primary lesion may sometimes remain unknown. In such cases, the condition is managed as a "cancer of unknown primary," and we provide specialized treatment—primarily with anti-cancer drugs—at this division. A physician experienced in managing numerous cases of unknown primaries will carefully evaluate the patient’s overall condition before recommending the best possible cancer treatment. While treatment most often involves anti-cancer drugs, some cases may require surgical intervention.

A Word from the Division Staff

While the number of hospitals accepting cancer of unknown primary in Shizuoka Prefecture is growing, it remains limited. Therefore, we aim to continue actively contributing to oncology and cancer medicine within this region.

Fields of Expertise, Professional Memberships and Credentials

Yusuke Onozawa, M.D., Chief

Fields of Expertise

chemotherapy for gastroenterological cancer (i.e., gastrointestinal lymphoma, gastrointestinal stromal tumor (GIST)) and cancer in the head and neck region

Professional Memberships and Credentials

Interim Supervisory Doctor, Councilor, Certified Specialist and Supervisory Doctor for Cancer Chemotherapy, the Japanese Society of Medical Oncology

General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy

Certified Physician, Specialist and Supervisory Doctor, the Japanese Society of Internal Medicine

Specialist Certified by the Japanese Society of Gastroenterology

The Japan Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO)
The Japanese Society of Hematology
The Japan Society for Head and Neck Cancer

The Japanese Society for Transplantation and Cellular Therapy

The Japan Society of Transfusion Medicine and Cell Therapy

The Japan Gastroenterological Endoscopy Society

Shizuoka Cancer Center

Shizuoka Cancer Center